The impact of mobile application: “Friends of Heart” in knowledge and compliance of patients with coronary heart disease

Background: The quality of life of coronary heart disease (CHD) patients can be improved by increasing patient compliance with treatment and health literacy rates. Over the past decade, mobile health (mHealth) has improved treatment adherence and demonstrated strong potential to increase health lite...

Full description

Bibliographic Details
Main Authors: Prima, D.A (Author), Putra, R.P (Author), Rochmawati, I.D (Author)
Format: Article
Language:English
Published: International Pharmaceutical Federation 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 01909nam a2200193Ia 4500
001 10.46542-pe.2022.222.3640
008 220510s2022 CNT 000 0 und d
020 |a 15602214 (ISSN) 
245 1 0 |a The impact of mobile application: “Friends of Heart” in knowledge and compliance of patients with coronary heart disease 
260 0 |b International Pharmaceutical Federation  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.46542/pe.2022.222.3640 
520 3 |a Background: The quality of life of coronary heart disease (CHD) patients can be improved by increasing patient compliance with treatment and health literacy rates. Over the past decade, mobile health (mHealth) has improved treatment adherence and demonstrated strong potential to increase health literacy rates. Objectives: Analyse the effect of “Friends of Heart” application on the compliance and knowledge of coronary heart disease patients. Methods: A randomized controlled trial (RCT) was conducted. The test group (intervention group) used the Sahabat Jantung/ “Friends of Heart” application developed for the Android 4.1 operating system, while the control group did not. Compliance was measured for 30 days in outpatient settings; it included pill count and time deviations in taking medication. Knowledge was assessed using questionnaires. Results: Statistical results showed significant differences in knowledge and adherence between the intervention and the control group (p = 0.0001). Conclusion: The use of the “Friends of Heart” application could improve compliance and knowledge of coronary heart disease patients. © 2022, International Pharmaceutical Federation. All rights reserved. 
650 0 4 |a Adherence 
650 0 4 |a Health mobile application 
650 0 4 |a Knowledge 
700 1 |a Prima, D.A.  |e author 
700 1 |a Putra, R.P.  |e author 
700 1 |a Rochmawati, I.D.  |e author 
773 |t Pharmacy Education